Comparative Transcriptome Analysis in Monocyte-Derived Macrophages of Asymptomatic <i>GBA</i> Mutation Carriers and Patients with GBA-Associated Parkinson’s Disease
Mutations of the <i>GBA</i> gene, encoding for lysosomal enzyme glucocerebrosidase (GCase), are the greatest genetic risk factor for Parkinson’s disease (PD) with frequency between 5% and 20% across the world. N370S and L444P are the two most common mutations in the <i>GBA</i>...
Main Authors: | Tatiana Usenko, Anastasia Bezrukova, Katerina Basharova, Alexandra Panteleeva, Mikhail Nikolaev, Alena Kopytova, Irina Miliukhina, Anton Emelyanov, Ekaterina Zakharova, Sofya Pchelina |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/12/10/1545 |
Similar Items
-
The Effect of p.G2019S Mutation in the LRRK2 Gene on the Activity of Lysosomal Hydrolases and the Clinical Features of Parkinson's Disease Associated with p.N370S Mutation in the GBA1 Gene
by: Tatiana S. Usenko, et al.
Published: (2024-01-01) -
Gene Expression of Lysosomal Membrane Proteins in Parkinson Disease, Associated with Mutations in the Glucocerebrosidase Gene (GBA)
by: Tatiana S. Usenko, et al.
Published: (2020-06-01) -
Biochemical Characteristics of iPSC-Derived Dopaminergic Neurons from N370S <i>GBA</i> Variant Carriers with and without Parkinson’s Disease
by: Elena V. Grigor’eva, et al.
Published: (2023-02-01) -
<i>GBA</i> Variants and Parkinson Disease: Mechanisms and Treatments
by: Laura Smith, et al.
Published: (2022-04-01) -
The Consequences of GBA Deficiency in the Autophagy–Lysosome System in Parkinson’s Disease Associated with GBA
by: Eddie Pradas, et al.
Published: (2023-01-01)